Related references
Note: Only part of the references are listed.Initial Cholinesterase Inhibitor Therapy Dose and Serious Events in Older Women and Men
Paula A. Rochon et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2018)
Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment
Sylvia Lombardo et al.
NEUROPHARMACOLOGY (2015)
Trends in use of psychotropic medications among patients treated with cholinesterase inhibitors in Japan from 2002 to 2010
Yasuyuki Okumura et al.
INTERNATIONAL PSYCHOGERIATRICS (2015)
Beyond Comorbidity Expanding the Definition and Measurement of Complexity Among Older Adults Using Administrative Claims Data
Elizabeth Chrischilles et al.
MEDICAL CARE (2014)
The Impact of Memantine and Cholinesterase Inhibitor Initiation for Alzheimer Disease on the Use of Antipsychotic Agents: Analysis Using the Regie de l'Assurance Maladie du Quebec Database
Jean Lachaine et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2013)
Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
Liesi E. Hebert et al.
NEUROLOGY (2013)
Atypical Antipsychotic Use in Patients With Dementia: Managing Safety Concerns
Martin Steinberg et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease
Gary Small et al.
ALZHEIMERS & DEMENTIA (2011)
Risk of Cerebrovascular Adverse Events and Death in Elderly Patients With Dementia When Treated With Antipsychotic Medications: A Literature Review of Evidence
Vikrant Mittal et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2011)
Prescribing pattern of psychotropic drugs in nursing home residents with dementia
R. B. Wetzels et al.
INTERNATIONAL PSYCHOGERIATRICS (2011)
An examination of Alzheimer's disease case definitions using Medicare claims and survey data
Pei-Jung Lin et al.
ALZHEIMERS & DEMENTIA (2010)
Use of Antipsychotic Drugs in Patients with Alzheimer's Disease Treated with Rivastigmine versus Donepezil A Retrospective, Parallel-Cohort, Hypothesis-Generating Study
Douglas W. Scharre et al.
DRUGS & AGING (2010)
Use of physical restraints and antipsychotic medications in nursing homes: a cross-national study
Zhanlian Feng et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2009)
Changes in utilisation of anticholinergic drugs after initiation of cholinesterase inhibitors
M. Robinson et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Effectiveness of cholinesterase inhibitors and memantine for treating dementia: Evidence review for a clinical practice guideline
Parminder Raina et al.
ANNALS OF INTERNAL MEDICINE (2008)
Current therapeutic options for Alzheimer's disease
Alberto Lleo
CURRENT GENOMICS (2007)
Effective pharmacologic management of Alzheimer's disease
Martin R. Farlow et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders
JL Cummings et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Cholinesterase inhibitors for Alzheimer's disease
J Birks
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
Antipsychotic drug use among nursing home residents taking rivastigmine
Siva Narayanan et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2006)
Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease
JL Cummings et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine
DC Suh et al.
DRUGS & AGING (2004)
Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week Alzheimer disease trial
M Farlow et al.
ARCHIVES OF NEUROLOGY (2003)
Cholinesterase inhibitors for the treatment of Alzheimer's disease: Getting on and staying on
GT Grossberg
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2003)
Prevalence and correlates of behavioral and psychiatric symptoms in community-dwelling elders with dementia or mild cognitive impairment: the Memory and Medical Care Study
DC Chan et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease
G Wilcock et al.
DRUGS & AGING (2003)
Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease
S Gauthier et al.
INTERNATIONAL PSYCHOGERIATRICS (2002)
Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment - Results from the Cardiovascular Health Study
CG Lyketsos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Advances in the treatment of Alzheimer's disease: Benefits of dual cholinesterase inhibition
CG Ballard
EUROPEAN NEUROLOGY (2002)
Share Paper
